Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980 Aug;10(2):145–150. doi: 10.1111/j.1365-2125.1980.tb01731.x

The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability.

I Hindmarch, A C Gudgeon
PMCID: PMC1430040  PMID: 6107116

Abstract

1 Laboratory tests of psychomotor performance and 'on road' assessments of car handling ability were made following repeated doses of clobazam 10 mg three times daily, lorazepam 1 mg three times daily and matching placebo 1 capsule three times daily. 2 Both active compounds produced on impairment, compared to placebo, in some mental arithmetic and letter cancellation tasks, but these effects were neither widespread nor consistent. 3 Lorazepam produced a significant impairment of car driving tasks and analogue rating scales of subjective alertness. The pronounced sedative activity of the drug was also shown in the verbal reports of side effects and in indices of early morning sedation derived from the Leeds Sleep Evaluation Questionnaire. 4 Clobazam did not produce either the objective, or the subjective impairment of performance and alertness found with lorazepam. 5 The results taken as a whole show important differences between the 1,4 benzodiazepine, lorazepam, and the 1,5 benzodiazepine, clobazam, in their effects on the integrity of psychomotor performance related to car driving ability.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell R. W., Dickie D. S., Stewart-Jones J., Turner P. Lorazepam on visuo-motor co-ordination and visual function in man. J Pharm Pharmacol. 1973 Jan;25(1):87–88. doi: 10.1111/j.2042-7158.1973.tb09126.x. [DOI] [PubMed] [Google Scholar]
  2. Betts T. A., Clayton A. B., Mackay G. M. Effects of four commonly-used tranquillizers on low-speed driving performance tests. Br Med J. 1972 Dec 9;4(5840):580–584. doi: 10.1136/bmj.4.5840.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bond A. J., Lader M. H. Residual effects of flunitrazepam. Br J Clin Pharmacol. 1975 Apr;2(2):143–150. doi: 10.1111/j.1365-2125.1975.tb01569.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bond A. J., Lader M. H. The residual effects of flurazepam. Psychopharmacologia. 1973 Sep 28;32(3):223–235. doi: 10.1007/BF00422145. [DOI] [PubMed] [Google Scholar]
  5. Borland R. G., Nicholson A. N. Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam. Br J Clin Pharmacol. 1975 Jun;2(3):215–221. doi: 10.1111/j.1365-2125.1975.tb01578.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doongaji D. R., Sheth A., Apte J. S., Lakdawala P. D., Khare C. B., Thatte S. S. Clobazam versus diazepam--a double-blind study in anxiety neurosis. J Clin Pharmacol. 1978 Jul;18(7):358–364. doi: 10.1002/j.1552-4604.1978.tb01606.x. [DOI] [PubMed] [Google Scholar]
  7. Elliott H. W., Nomof N., Navarro G., Ruelius H. W., Knowles J. A., Comer W. H. Central nervous system and cardiovascular effects of lorazepam in man. Clin Pharmacol Ther. 1971 May-Jun;12(3):468–481. doi: 10.1002/cpt1971123468. [DOI] [PubMed] [Google Scholar]
  8. Farhoumand N., Harrison J., Pare C. M., Turner P., Wynn S. The effect of high dose oxprenolol on stress-induced physical and psychophysiological variables. Psychopharmacology (Berl) 1979 Sep;64(3):365–369. doi: 10.1007/BF00427526. [DOI] [PubMed] [Google Scholar]
  9. Globus G., Phoebus E., Humphries J., Boyd R., Gaffney D., Gaffney S. The effect of lorazepam on anxious insomniacs' sleep as recorded in the home environment. J Clin Pharmacol. 1974 Apr;14(4):192–201. doi: 10.1002/j.1552-4604.1974.tb01397.x. [DOI] [PubMed] [Google Scholar]
  10. Harry T. V., Richards D. J. Lorazepam--a study in psychomotor depression. Br J Clin Pract. 1972 Aug;26(8):371–373. [PubMed] [Google Scholar]
  11. Hedges A., Turner P., Harry T. V. Preliminary studies on the central effects of lorazepam, a new benzodiazepine. J Clin Pharmacol New Drugs. 1971 Nov-Dec;11(6):423–427. [PubMed] [Google Scholar]
  12. Hindmarch I. A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour. Arzneimittelforschung. 1975 Nov;25(11):1836–1839. [PubMed] [Google Scholar]
  13. Hindmarch I. A preliminary study of the effects of prepeated doses of clobazam on aspects of performance, arousal and behaviour in a group of anxiety rated volunteers. Eur J Clin Pharmacol. 1979 Aug;16(1):17–21. doi: 10.1007/BF00644961. [DOI] [PubMed] [Google Scholar]
  14. Hindmarch I. A repeated dose comparison of three benzodiazepine derivative (nitrazepam, flurazepam and flunitrazepam) on subjective appraisals of sleep and measures of psychomotor performance the morning following night-time medication. Acta Psychiatr Scand. 1977 Nov;56(5):373–381. doi: 10.1111/j.1600-0447.1977.tb06678.x. [DOI] [PubMed] [Google Scholar]
  15. Hindmarch I. A sub-chronic study of the subjective quality of sleep and psychological measures of performance on the morning following night time medication with temazepam. Arzneimittelforschung. 1976;26(11):2113–2115. [PubMed] [Google Scholar]
  16. Hindmarch I., Hanks G. W., Hewett A. J. Clobazam, a 1,5-benzodiazepine, and car-driving ability. Br J Clin Pharmacol. 1977 Oct;4(5):573–578. doi: 10.1111/j.1365-2125.1977.tb00788.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hindmarch I., Parrott A. C., Lanza M. The effects of an ergot alkaloid derivative (Hydergine) on aspects of psychomotor performance, arousal, and cognitive processing ability. J Clin Pharmacol. 1979 Nov-Dec;19(11-12):726–732. doi: 10.1002/j.1552-4604.1979.tb01643.x. [DOI] [PubMed] [Google Scholar]
  18. Hindmarch I., Parrott A. C. The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication. Arzneimittelforschung. 1978;28(11):2169–2172. [PubMed] [Google Scholar]
  19. Hindmarch I., Parrott A. C. The effects of repeated nocturnal doses of clobazam, dipotassium chlorazepate and placebo on subjective ratings of sleep and early morning behaviour and objective measures of arousal, psychomotor performance and anxiety. Br J Clin Pharmacol. 1979 Oct;8(4):325–329. doi: 10.1111/j.1365-2125.1979.tb04713.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hindmarch I. Some aspects of the effects of clobazam on human psychomotor performance. Br J Clin Pharmacol. 1979;7 (Suppl 1):77S–82S. doi: 10.1111/j.1365-2125.1979.tb04669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knowles J. A., Comer W. H., Ruelius H. W. Disposition of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in humans. Determination of the drug by electron capture gas chromatography. Arzneimittelforschung. 1971 Jul;21(7):1055–1059. [PubMed] [Google Scholar]
  22. Malpas A., Legg N. J., Scott D. F. Effects of hypnotics on anxious patients. Br J Psychiatry. 1974 May;124(0):482–484. doi: 10.1192/bjp.124.5.482. [DOI] [PubMed] [Google Scholar]
  23. Norris W., Wallace P. G. Wy 4036 (lorazepam): a study of its use in premedication. Br J Anaesth. 1971 Aug;43(8):785–789. doi: 10.1093/bja/43.8.785. [DOI] [PubMed] [Google Scholar]
  24. Parrott A. C., Hindmarch I. Factor analysis of a sleep evaluation questionnaire. Psychol Med. 1978 May;8(2):325–329. doi: 10.1017/s0033291700014379. [DOI] [PubMed] [Google Scholar]
  25. Rupp W., Badian M., Christ O., Hajdú P., Kulkarni R. D., Taeuber K., Uihlein M., Bender R., Vanderbeke O. Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol. 1979;7 (Suppl 1):51S–57S. doi: 10.1111/j.1365-2125.1979.tb04665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Salkind M. R., Hanks G. W., Silverstone J. T. Evaluation of the effects of clobazam, A 1,5 benzodiazepine, on mood and psychomotor performance in clinically anxious patients in general practice. Br J Clin Pharmacol. 1979;7 (Suppl 1):113S–118S. doi: 10.1111/j.1365-2125.1979.tb04676.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Seppälä K., Korttila K., Häkkinen S., Linnoila M. Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam. Br J Clin Pharmacol. 1976 Oct;3(5):831–841. doi: 10.1111/j.1365-2125.1976.tb00635.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Straughan J. L. Which benzodiazepine, why and how? S Afr Med J. 1979 Jun 30;55(27):1110–1114. [PubMed] [Google Scholar]
  29. Turner P. Clinical pharmacological studies on lorazepam. Curr Med Res Opin. 1973;1(5):262–264. doi: 10.1185/03007997309111675. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES